InventionMed S.A. (WSE:INM)

Market Cap	22.41M -34.6%
Revenue (ttm)	3.74M +684.2%
Net Income	42.15K
EPS	0.00
Shares Out	202.79M
PE Ratio	531.65
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	319,408
Open	0.1040
Previous Close	0.1055
Day's Range	0.1040 - 0.1105
52-Week Range	0.0972 - 0.1700
Beta	0.36
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About InventionMed

InventionMed S.A. focuses on the development of medical simulators based on Virtual Realty technology for use in education in esthetic and clinical dermatology. The company flagship project is TutorDerm, a simulator and an application that lets users perform actions necessary to treat specific dermatological diseases. It also offers double immersion, and Virtual Syringe, a training equipment for specialists in clinical and aesthetic dermatology. In addition, the company provides education and training services, as well as simulators of medical ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2012
• Employees: 4
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: INM

Financial Performance

In 2025, InventionMed's revenue was 3.17 million, an increase of 1041.56% compared to the previous year's 277,760. Losses were -749,410, -82.99% less than in 2024.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 15, 2026

Data Sources Report a data error